HARVARD BIOSCIENCE INC

Harvard Bioscience insiders surge post‑reverse split, buying 16,556 shares at $6.42 to cash in on a 7.7% weekly rise and 30% yearly gain.

Harvard Bioscience CEO buys 10,000 shares after reverse split, signalling confidence in undervalued proteomics tools and potential price rebound.

Harvard Bioscience insider buying post‑reverse split signals confidence but also risks—find out how this may affect your next investment decision.

Harvard Bioscience CEO’s 5,000‑share purchase signals confidence amid volatile markets, underscoring the firm’s proteomics tech potential and long‑term value.